My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

Neurogen Biomarking will present novel data on at-home p-tau 217 testing for Alzheimer’s disease at the upcoming Alzheimer’s Association International Conference® (AAIC) in Toronto, Canada. Chief ...

California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...

Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics ...

The Alzheimer's Association of Greater Kentucky and Southern Indiana held the kickoff party on Wednesday for its Walk to End ...

New research involving nearly 93,000 adults reveals that following a Mediterranean-style eating pattern significantly reduces Alzheimer's risk. The study shows even people who start healthy eating ...

Leqembi is the first FDA-approved drug shown to slow the progression of early-stage Alzheimer’s. Medi-Cal can cover Leqembi ...

WHY do some people develop dementia, while others don’t? It’s a question that’s baffled scientists for decades. Some blame ...

Now, scientists say that eating just a couple of eggs a week could significantly reduce Alzheimer’s risk in older adults.

A free database of biomarker information on neurodegenerative diseases was released with backing from Bill Gates, Johnson & ...

Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's, ...